A compounding pharmacy at the center of a national outbreak of fungal meningitis has voluntarily recalled all of its products, including numerous drugs for treating skin conditions.
The Weekly Roundup: May 29-June 2
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
WHO Calls For Caution When it Comes to Using AI For Health
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
European Commission Approves Secukinumab for Hidradenitis Suppurativa
Addressing Disparities and Ensuring Equitable Care for LGBTQIA+ Patients
2 Clarke Drive Cranbury, NJ 08512